Viking Therapeutics Inc
NASDAQ:VKTX

Watchlist Manager
Viking Therapeutics Inc Logo
Viking Therapeutics Inc
NASDAQ:VKTX
Watchlist
Price: 35.18 USD Market Closed
Market Cap: 4B USD

Wall Street
Price Targets

VKTX Price Targets Summary
Viking Therapeutics Inc

Wall Street analysts forecast VKTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VKTX is 95.12 USD with a low forecast of 36.36 USD and a high forecast of 131.25 USD.

Lowest
Price Target
36.36 USD
3% Upside
Average
Price Target
95.12 USD
170% Upside
Highest
Price Target
131.25 USD
273% Upside
Viking Therapeutics Inc Competitors:
Price Targets
87S
Roivant Sciences Ltd
13% Upside
IPH
Innate Pharma SA
212% Upside
MNKD
MannKind Corp
63% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
35% Upside
CDNA
CareDx Inc
25% Upside
MGX
Metagenomi Inc
488% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
29% Upside
600201
Jinyu Bio-Technology Co Ltd
39% Downside

Revenue
Forecast

Revenue Estimate
Viking Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Viking Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Viking Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VKTX's stock price target?
Price Target
95.12 USD

According to Wall Street analysts, the average 1-year price target for VKTX is 95.12 USD with a low forecast of 36.36 USD and a high forecast of 131.25 USD.

Back to Top